BR0309743A - Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados - Google Patents

Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados

Info

Publication number
BR0309743A
BR0309743A BR0309743-9A BR0309743A BR0309743A BR 0309743 A BR0309743 A BR 0309743A BR 0309743 A BR0309743 A BR 0309743A BR 0309743 A BR0309743 A BR 0309743A
Authority
BR
Brazil
Prior art keywords
gamma
butyrolactams
preparation
amino acids
highly functionalized
Prior art date
Application number
BR0309743-9A
Other languages
English (en)
Inventor
Peter Garth Blazecka
James Guy Davidson Iii
Ji Zhang
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0309743A publication Critical patent/BR0309743A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36—Oxygen or sulfur atoms
    • C07D207/38—2-Pyrrolones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)

Abstract

"PROCESSO PARA A PREPARAçãO DE GAMA-BUTIROLACTAMAS E GAMA-AMINOáCIDOS ALTAMENTE FUNCIONALIZADOS". A presente invenção refere-se a um processo para a preparação de <sym>-butirolactamas e <sym>-aminoácidos altamente funcionalizados por aminação redutiva de ácido muco-hálico ou dos seus derivados, e descreve um processo para a preparação de pregabalina ou ácido 3-aminometil-5-metil-octanóico, análogos de GABA com atividade medicinal desejável (Fórmula I).
BR0309743-9A 2002-04-30 2003-04-17 Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados BR0309743A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37699102P 2002-04-30 2002-04-30
PCT/IB2003/001646 WO2003093220A1 (en) 2002-04-30 2003-04-17 Process for preparing highly functionalized y-butyrolactams and y-amino acids

Publications (1)

Publication Number Publication Date
BR0309743A true BR0309743A (pt) 2005-02-09

Family

ID=29401429

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309743-9A BR0309743A (pt) 2002-04-30 2003-04-17 Processo para a preparação de gama-butirolactamas e gama-aminoácidos altamente funcionalizados

Country Status (15)

Country Link
US (2) US20030225149A1 (pt)
EP (1) EP1499583A1 (pt)
JP (1) JP2005523932A (pt)
KR (1) KR20040106415A (pt)
CN (1) CN1649827A (pt)
AR (1) AR039467A1 (pt)
AU (1) AU2003219425A1 (pt)
BR (1) BR0309743A (pt)
CA (1) CA2483830A1 (pt)
IL (1) IL164781A0 (pt)
MX (1) MXPA04010771A (pt)
PL (1) PL373296A1 (pt)
RU (1) RU2004131840A (pt)
TW (1) TW200400929A (pt)
WO (1) WO2003093220A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0934061B3 (en) 1996-07-24 2015-01-21 Warner-Lambert Company LLC Isobutylgaba and its derivatives for the treatment of pain
CN1972904B (zh) * 2004-06-21 2011-02-02 沃尼尔·朗伯有限责任公司 普瑞巴林和相关化合物的制备
KR20140066210A (ko) 2004-08-04 2014-05-30 포움 서플라이즈 인코포레이션 폴리우레탄 폼에서의 반응도 변동 및 촉매 분해
CN101160281A (zh) * 2005-04-06 2008-04-09 特瓦制药工业有限公司 结晶形态的普瑞巴林
MX2007012606A (es) * 2005-04-11 2008-01-11 Teva Pharma Proceso para elaborar (s)-pregabalina.
US7488846B2 (en) * 2005-04-11 2009-02-10 Teva Pharmaceuical Industries Ltd. Pregabalin free of lactam and a process for preparation thereof
WO2006122258A1 (en) * 2005-05-10 2006-11-16 Teva Pharmaceutical Industries Ltd. Method for the preparation of pregabalin and salts thereof
MX2007000525A (es) 2005-05-10 2007-03-28 Teva Pharma Pregabalina libre de acido isobutilglutarico y un proceso para la preparacion de ella.
ES2372700T3 (es) * 2005-05-10 2012-01-25 Teva Pharmaceutical Industries Ltd Resolución óptica del ácido 3-carbamoilmetil-5-metil hexanoico.
CZ297970B6 (cs) * 2005-08-10 2007-05-09 Zentiva, A. S Zpusob výroby (S)-3-(aminomethyl)-5-methyl-hexanové kyseliny (pregabalinu)
WO2007035789A1 (en) * 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. Chiral 3-carbamoylmethyl-5-methyl hexanoic acids, key intermediates for the new synthesis of (s)-pregabalin
WO2007127309A2 (en) * 2006-04-24 2007-11-08 Teva Pharmaceutical Industries Ltd. Processes for the synthesis of 3-isobutylglutaric acid
WO2007139933A2 (en) * 2006-05-24 2007-12-06 Teva Pharmaceutical Industries Ltd. Processes for the preparation of r-(+)-3-(carbamoyl methyl)-5-methylhexanoic acid and salts thereof
WO2007143113A2 (en) * 2006-05-31 2007-12-13 Teva Pharmaceutical Industries Ltd. The use of enzymatic resolution for the preparation of intermediates of pregabalin
WO2007143152A2 (en) * 2006-05-31 2007-12-13 Teva Pharmaceutical Industries Ltd. Preparation of (s)-pregabalin-nitrile
TW200846308A (en) * 2007-03-22 2008-12-01 Teva Pharma Synthesis of (s)-(+)-3-(aminomethyl)-5-methyl hexanoic acid
WO2008127646A2 (en) * 2007-04-11 2008-10-23 Dsm Ip Assets B.V. Transaminase-based processes for preparation of pregabalin
MY162330A (en) * 2007-06-05 2017-05-31 Akzo Nobel Coatings Inc Radiation curable coating composition derived from epoxidized vegetable oils
WO2009046309A2 (en) * 2007-10-03 2009-04-09 Teva Pharmaceutical Industries Ltd. Pregabalin -4-eliminate, pregabalin 5-eliminate, their use as reference marker and standard, and method to produce pregabalin containing low levels thereof
EP2222630A1 (en) * 2007-12-26 2010-09-01 Generics (UK) Limited Processes to pregabalin
SG157299A1 (en) 2008-05-09 2009-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
WO2009158343A1 (en) * 2008-06-23 2009-12-30 Teva Pharmaceutical Industries, Ltd. Stereoselective enzymatic synthesis of (s) or (r)-iso-butyl-glutaric ester
ES2693159T3 (es) 2009-03-05 2018-12-07 Akzo Nobel Coatings International B.V. Copolímeros de injerto acrílicos de poliol de aceite con funcionalidad hidroxilo
WO2011086565A1 (en) * 2010-01-15 2011-07-21 Lupin Limited Method for preparation of enantiomerically enriched and/or racemic gamma-amino acids
MX2013007459A (es) 2010-12-28 2013-07-29 Akzo Nobel Coatings Int Bv Composiciones de recubrimiento curable por radiacion para metal.
GB201121317D0 (en) 2011-12-09 2012-01-25 Syngenta Ltd Herbicidal compounds
WO2013092541A1 (en) 2011-12-21 2013-06-27 Akzo Nobel Coatings International B.V. Solvent-based coating compositions
RU2606632C2 (ru) 2011-12-21 2017-01-10 Акцо Нобель Коатингс Интернэшнл Б.В. Композиции на водной основе для получения покрытий
BR112015024859A2 (pt) * 2013-03-27 2017-10-10 Pfizer Ireland Pharmaceuticals processo e intermediários para a preparação de pregabalina

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935210A (en) 1971-07-29 1976-01-27 Sandoz, Inc. Preparation of 1-aryl-4,5-dihalo-pyridazone-6
DK0641330T3 (da) * 1992-05-20 2001-12-03 Univ Northwestern Gaba- og L-glutaminsyreanaloger til antikrampeanfaldsbehandling
DZ2770A1 (fr) 1998-04-17 2003-12-01 Lilly Co Eli Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
BR9911887A (pt) 1998-07-09 2001-03-27 Warner Lambert Co Método para o tratamento da insÈnia
CZ300834B6 (cs) * 1999-06-10 2009-08-19 Warner-Lambert Company Llc Mono- a disubstituované kyseliny 3-propyl-gamma-aminomáselné

Also Published As

Publication number Publication date
EP1499583A1 (en) 2005-01-26
TW200400929A (en) 2004-01-16
IL164781A0 (en) 2005-12-18
KR20040106415A (ko) 2004-12-17
MXPA04010771A (es) 2005-03-07
JP2005523932A (ja) 2005-08-11
CA2483830A1 (en) 2003-11-13
RU2004131840A (ru) 2005-05-27
AU2003219425A1 (en) 2003-11-17
WO2003093220A1 (en) 2003-11-13
CN1649827A (zh) 2005-08-03
PL373296A1 (en) 2005-08-22
US6924377B2 (en) 2005-08-02
US20030236415A1 (en) 2003-12-25
AR039467A1 (es) 2005-02-23
US20030225149A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
BRPI0016395B8 (pt) derivados de adamantano
BR0213380A (pt) Derivados propiÈnicos alfa-oxissubstituìdos por beta-fenila: processo para sua preparação e seu uso na preparação de compostos farmaceuticamente importantes
BR9713465A (pt) Inibidores metalotprotease de amina cìclica sibstituìda
BRPI0409227B8 (pt) &#34;composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)&#34;
NO20083956L (no) Prodrugs av GABA-analoger, sammensetninger og anvendelse derav
BR9808540A (pt) Composto, processo para a preparação do mesmo, composição farmacêutica e processo para preparação dos mesmos, uso de um composto, e, processo para produzir a imunossupressão
BR0314314A (pt) Derivados do éter 4-pirrolidina-fenil-benzìlico
AR039467A1 (es) Procedimiento para preparar gama-butirolactamas y gama-aminoacidos muy funcionalizados
BRPI0409624A (pt) 2-hidróxi-3-diaminoalcanos de benzamida
BR0310077A (pt) Novos compostos e sua utilização
BRPI0008753B8 (pt) composto de amida, processo para preparar um composto de amida, composição farmacêutica e uso de um composto de amida
BR0311984A (pt) Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação
BR0206935A (pt) Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto
BRPI0507786A (pt) composto e sais farmaceuticamente aceitáveis do mesmo, formulação farmacêutica, uso de um composto, método de tratar uma doença, e, processo para a preparação de compostos
BR0311896A (pt) Difenilazetidinonas substituìdas com grupos ácidos, processo para sua preparação, medicamentos contendo estes compostos e seu uso
BR0212069A (pt) Agentes antidiabéticos orais
BRPI0208468B8 (pt) camsilato de amlodipina e processo para sua preparação
BR0301667A (pt) Processo para a preparação de polìmeros em emulsão com pureza elevada
BR0313727A (pt) Derivados de isoquinolina como inibidores de metaloproteinase da matriz
WO2006047575A3 (en) Salts of isophosphoramide mustard and analogs thereof as anti-tumor agents
BRPI0409038A (pt) processos para preparação de um produto de reação, de uma composição farmacêutica, de uma composição agroquìmica, de uma composição de limpeza, de uma composição de tinta e de um refrigerante ou lubrificante
BR0316702A (pt) xprocesso para preparação de (s)-pantoprazol
BRPI0408270A (pt) composição farmacêutica compreendendo ácido 5-metil-2-(2&#39;cloro-6&#39;-fluoroanilino)fenilacético
BR0307009A (pt) Sais estáveis de ácido o-acetilsalicìlico com aminoácidos básicos ii
BR0115755A (pt) Processo para preparação de ácido 1-(aminometil) ciclohexano-acético

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.

B08J Incorrect entry in the gazette republished [chapter 8.10 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2105 DE 10/05/2011. TEXTO CORRETO: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2055 DE 25/05/2010.